产品详情
In vitro (25°C) | DMSO | 85 mg/mL (184.58 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 0.5% CMC+0.25% Tween 80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.72 mL | 108.58 mL | 217.16 mL |
0.5 mM | 4.34 mL | 21.72 mL | 43.43 mL |
1 mM | 2.17 mL | 10.86 mL | 21.72 mL |
5 mM | 0.43 mL | 2.17 mL | 4.34 mL |
*The above data is based on the productmolecular weight 460.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11289 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 460.5 |
Formula | C22H24N2O7S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 608141-41-9 |
Synonyms | CC10004, CC-10004 |
SMILES | CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC |
产品资料
产品标签
Product Questions
Product Questions
Thalidomide
Thalidomide可以在体内直接抑制bFGF或VEGF诱导的血管生成。
Necrostatin-1
Necrostatin-1是一种与ATP竞争的,与受体相互作用的蛋白激酶1(RIPK1)的变构抑制剂(EC50 = 182 nM)。
Pomalidomide (CC-4047)
Pomalidomide (CC-4047)是沙利度胺的衍生物,在PBMCs中IC50为13 nM,并起免疫调节剂的作用。
QNZ (EVP4593)
QNZ抑制转录因子NF-κB的激活,已被用于研究NF-κB信号传导。
Lenalidomide (CC-5013)
Lenalidomide (CC-5013)是Thalidomide的衍生物。在体外,Lenalidomide具有三种主要活性:直接抗肿瘤作用、抑制肿瘤细…